# Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection

> **NCT00811863** · — · WITHDRAWN · sponsor: **Guerbet**

## Conditions studied

- Nephrogenic Systemic Fibrosis
- Renal Insufficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00811863
- **Lead sponsor:** Guerbet
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-02
- **Primary completion:** 2012-05-17
- **Final completion:** 2012-05-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study drug currently unavailable
- **Last updated:** 2017-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00811863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00811863, "Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00811863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*